MiR-155-5p Attenuates Vascular Smooth Muscle Cell Oxidative Stress and Migration via Inhibiting BACH1 Expression.

BACH1 miR-155-5p migration oxidative stress vascular smooth muscle cells

Journal

Biomedicines
ISSN: 2227-9059
Titre abrégé: Biomedicines
Pays: Switzerland
ID NLM: 101691304

Informations de publication

Date de publication:
09 Jun 2023
Historique:
received: 25 04 2023
revised: 03 06 2023
accepted: 08 06 2023
medline: 28 6 2023
pubmed: 28 6 2023
entrez: 28 6 2023
Statut: epublish

Résumé

The malfunction of vascular smooth muscle cells (VSMCs) is an initiating factor in the pathogenesis of pathological vascular remodeling, including hypertension-related vascular lesions. MicroRNAs (miRNAs) have been implicated in the pathogenesis of VSMC proliferation and migration in numerous cases of cardiovascular remodeling. The evidence for the regulatory role of miR-155-5p in the development of the cardiovascular system has been emerging. However, it was previously unclear whether miR-155-5p participated in the migration of VSMCs under hypertensive conditions. Thus, we aimed to define the exact role and action of miR-155-5p in VSMC migration by hypertension. Here, we detected that the level of miR-155-5p was lower in primary VSMCs from spontaneously hypertensive rats (SHRs). Its overexpression attenuated, while its depletion accelerated, the migration and oxidative damage of VSMCs from SHRs. Our dual-luciferase reporter assay showed that miRNA-155-5p directly targeted the 3'-untranslated region (3'-UTR) of BTB and CNC homology 1 (BACH1). The miR-155-5p mimic inhibited BACH1 upregulation in SHR VSMCs. By contrast, the deletion of miR-155-5p further elevated the upregulation of BACH1 in SHR-derived VSMCs. Importantly, the overexpression of miR-155-5p and knockdown of BACH1 had synergistic effects on the inhibition of VSMCs in hypertension. Collectively, miR-155-5p attenuates VSMC migration and ameliorates vascular remodeling in SHRs, via suppressing BACH1 expression.

Identifiants

pubmed: 37371773
pii: biomedicines11061679
doi: 10.3390/biomedicines11061679
pmc: PMC10295705
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : National Natural Science Foundation of China
ID : 82200475; 82100018
Organisme : Natural Science Foundation of Jiangsu Province
ID : BK20221087; BK20200602
Organisme : China Postdoctoral Science Foundation
ID : 2020M671347

Références

Antioxidants (Basel). 2020 Mar 01;9(3):
pubmed: 32121598
J Am Soc Hypertens. 2017 Dec;11(12):831-841.e4
pubmed: 29146158
J Biol Chem. 2021 Sep;297(3):101032
pubmed: 34339740
Int J Mol Sci. 2020 Nov 20;21(22):
pubmed: 33233489
Life Sci. 2021 Dec 15;287:120091
pubmed: 34717910
PLoS One. 2015 Sep 22;10(9):e0138383
pubmed: 26394310
Cardiovasc Drugs Ther. 2022 Feb;36(1):157-172
pubmed: 32964302
Circulation. 2016 Dec 13;134(24):1973-1990
pubmed: 27780851
J Biol Chem. 2018 Sep 21;293(38):14812-14822
pubmed: 30104414
J Hypertens. 2018 Nov;36(11):2226-2236
pubmed: 30256768
Cardiovasc Res. 2018 Mar 15;114(4):513-528
pubmed: 29514201
JCI Insight. 2016 Sep 08;1(14):e88942
pubmed: 27683672
Biochem J. 2021 Oct 29;478(20):3741-3756
pubmed: 34605540
FEBS J. 2023 Apr;290(7):1688-1704
pubmed: 35107212
Hypertens Res. 2020 Jul;43(7):597-608
pubmed: 32020084
Trends Mol Med. 2017 Jan;23(1):31-45
pubmed: 27989641
Biochem Pharmacol. 2022 May;199:115008
pubmed: 35318039
Bioengineered. 2022 May;13(5):12985-12997
pubmed: 35611851
Nucleic Acids Res. 2004 Jan 1;32(Database issue):D109-11
pubmed: 14681370
Front Physiol. 2022 Apr 01;13:848867
pubmed: 35530510
Hypertens Res. 2021 Feb;44(2):129-146
pubmed: 32985618
J Extracell Vesicles. 2019 Dec 2;9(1):1698795
pubmed: 31839907
J Cell Mol Med. 2020 Jan;24(2):1700-1712
pubmed: 31782248
Genes Cells. 2005 Mar;10(3):277-85
pubmed: 15743416
Eur J Pharmacol. 2019 Jun 15;853:145-152
pubmed: 30898623
EMBO J. 2002 Oct 1;21(19):5216-24
pubmed: 12356737
Antioxid Redox Signal. 2019 Dec 20;31(18):1352-1370
pubmed: 31578871
J Cell Mol Med. 2021 Jan;25(1):535-548
pubmed: 33210462
Vascul Pharmacol. 2018 Feb;101:48-56
pubmed: 29277292
Mol Biol Rep. 2020 Jul;47(7):5535-5547
pubmed: 32567025
J Cell Biochem. 2015 Dec;116(12):2870-81
pubmed: 26012521
Redox Biol. 2018 Apr;14:656-668
pubmed: 29175753
Thromb Haemost. 2012 Apr;107(4):611-8
pubmed: 22371089

Auteurs

Ying Tong (Y)

Department of Physiopathology, Wuxi School of Medicine, Jiangnan University, 1800 Lihu Avenue, Binhu District, Wuxi 214122, China.
Department of Pathophysiology, Nanjing Medical University, Nanjing 211166, China.

Mei-Hui Zhou (MH)

Department of Physiopathology, Wuxi School of Medicine, Jiangnan University, 1800 Lihu Avenue, Binhu District, Wuxi 214122, China.

Sheng-Peng Li (SP)

Department of Physiopathology, Wuxi School of Medicine, Jiangnan University, 1800 Lihu Avenue, Binhu District, Wuxi 214122, China.

Hui-Min Zhao (HM)

Department of Physiopathology, Wuxi School of Medicine, Jiangnan University, 1800 Lihu Avenue, Binhu District, Wuxi 214122, China.

Ya-Ru Zhang (YR)

Department of Physiopathology, Wuxi School of Medicine, Jiangnan University, 1800 Lihu Avenue, Binhu District, Wuxi 214122, China.

Dan Chen (D)

Department of Physiopathology, Wuxi School of Medicine, Jiangnan University, 1800 Lihu Avenue, Binhu District, Wuxi 214122, China.

Ya-Xian Wu (YX)

Department of Physiopathology, Wuxi School of Medicine, Jiangnan University, 1800 Lihu Avenue, Binhu District, Wuxi 214122, China.

Qing-Feng Pang (QF)

Department of Physiopathology, Wuxi School of Medicine, Jiangnan University, 1800 Lihu Avenue, Binhu District, Wuxi 214122, China.

Classifications MeSH